• Je něco špatně v tomto záznamu ?

The prevalence of maternal hypothyroidism in first trimester screening from 11 to 14 weeks of gestation

T. Salek, I. Dhaifalah, D. Langova, J. Havalova

. 2019 ; 163 (3) : 265-268. [pub] 20181106

Jazyk angličtina Země Česko

Typ dokumentu srovnávací studie, časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc20005464

AIM: The aim of this study was to determine the prevalence of maternal hypothyroidism in the first trimester from 11 to 14 weeks of gestation according to the American Thyroid Association (ATA) guidelines from 2017 and to compare the rates for singleton and twin pregnancies. METHODS: A total of 4965 consecutive Caucasian singleton pregnancies and 109 Caucasian twin pregnancies were included in the investigation. Patients with a history of thyroid gland disorder were excluded. Subclinical maternal hypothyroidism was defined as a thyroid stimulating hormone (TSH) concentration above the 97.5th percentile and free thyroxine (fT4) within the range of a reference population of women at 11-14 weeks of gestation. Overt maternal hypothyroidism was defined as a TSH concentration above the 97.5th percentile and an fT4 below the 2.5th percentile of the reference population.TSH, fT4, and anti thyroid peroxidase antibody (TPOAb) were measured by immunochemiluminescent assays on an 16200 Abbott Architect analyzer. RESULTS: The prevalence of hypothyroidism for twin pregnancies was no higher than that for singleton pregnancies; 6.42% (7/109) vs. 5.32% (264/4965), respectively; P=0.61. All twin pregnancies were subclinical. Singleton hypothyroid pregnancies included 4.91% (244 cases) of subclinical and 0.41% (20 cases) of overt hypothyroidism. The prevalence of TPOAb positive hypothyroid women for twin pregnancies and singleton pregnancies was 71% (5/7) vs. 52% (137/264 cases), respectively but the differences were not statistically significant; P=0.31. CONCLUSION: Each first trimester screening center should establish its TSH and fT4 reference ranges. Our center had higher upper reference limits of TSH than that of the universally fixed limit of 2.5 mU/L, which led to a lower measured prevalence of maternal hypothyroidism. A large number of hypothyroid women were TPOAb positive.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc20005464
003      
CZ-PrNML
005      
20200607105858.0
007      
ta
008      
200511s2019 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2018.063 $2 doi
035    __
$a (PubMed)30401989
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Šálek, Tomáš, $d 1974- $7 xx0174625 $u Department of Clinical Biochemistry and Pharmacology, Tomas Bata Hospital in Zlin a. s., Zlin, Czech Republic; Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Ostrava - Zabreh, Czech Republic
245    14
$a The prevalence of maternal hypothyroidism in first trimester screening from 11 to 14 weeks of gestation / $c T. Salek, I. Dhaifalah, D. Langova, J. Havalova
504    __
$a Literatura
520    9_
$a AIM: The aim of this study was to determine the prevalence of maternal hypothyroidism in the first trimester from 11 to 14 weeks of gestation according to the American Thyroid Association (ATA) guidelines from 2017 and to compare the rates for singleton and twin pregnancies. METHODS: A total of 4965 consecutive Caucasian singleton pregnancies and 109 Caucasian twin pregnancies were included in the investigation. Patients with a history of thyroid gland disorder were excluded. Subclinical maternal hypothyroidism was defined as a thyroid stimulating hormone (TSH) concentration above the 97.5th percentile and free thyroxine (fT4) within the range of a reference population of women at 11-14 weeks of gestation. Overt maternal hypothyroidism was defined as a TSH concentration above the 97.5th percentile and an fT4 below the 2.5th percentile of the reference population.TSH, fT4, and anti thyroid peroxidase antibody (TPOAb) were measured by immunochemiluminescent assays on an 16200 Abbott Architect analyzer. RESULTS: The prevalence of hypothyroidism for twin pregnancies was no higher than that for singleton pregnancies; 6.42% (7/109) vs. 5.32% (264/4965), respectively; P=0.61. All twin pregnancies were subclinical. Singleton hypothyroid pregnancies included 4.91% (244 cases) of subclinical and 0.41% (20 cases) of overt hypothyroidism. The prevalence of TPOAb positive hypothyroid women for twin pregnancies and singleton pregnancies was 71% (5/7) vs. 52% (137/264 cases), respectively but the differences were not statistically significant; P=0.31. CONCLUSION: Each first trimester screening center should establish its TSH and fT4 reference ranges. Our center had higher upper reference limits of TSH than that of the universally fixed limit of 2.5 mU/L, which led to a lower measured prevalence of maternal hypothyroidism. A large number of hypothyroid women were TPOAb positive.
650    _2
$a dospělí $7 D000328
650    _2
$a protilátky $x metabolismus $7 D000906
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hypotyreóza $x krev $x diagnóza $7 D007037
650    _2
$a imunoanalýza $x metody $7 D007118
650    _2
$a jodidperoxidasa $x imunologie $7 D007453
650    _2
$a těhotenství $7 D011247
650    _2
$a komplikace těhotenství $x krev $x diagnóza $7 D011248
650    _2
$a první trimestr těhotenství $7 D011261
650    _2
$a těhotenství s dvojčaty $x fyziologie $7 D059285
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a thyreotropin $x metabolismus $7 D013972
650    _2
$a thyroxin $x metabolismus $7 D013974
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Dhaifalah, Ishraq A., $d 1964- $7 xx0018900 $u Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Ostrava - Zabreh, Czech Republic; Department of Obstetrics and Gynecology, Tomas Bata Hospital in Zlin a. s., Zlin, Czech Republic; FETMED (Fetmed Fetal Medicine Center and Genetics), Olomouc and Ostrava, Czech Republic
700    1_
$a Langová, Dagmar $7 xx0074076 $u Internal Medicine Clinic, Tomas Bata Hospital in Zlin a. s., Zlin, Czech Republic
700    1_
$a Havalová, Jana $7 xx0248656 $u Department of Obstetrics and Gynecology, Tomas Bata Hospital in Zlin a. s., Zlin, Czech Republic
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 163, č. 3 (2019), s. 265-268
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30401989 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200607105857 $b ABA008
999    __
$a ok $b bmc $g 1530818 $s 1095519
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 163 $c 3 $d 265-268 $e 20181106 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20200511

Najít záznam

Citační ukazatele

Možnosti archivace